ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2022 American Transplant Congress

    Higher Hepatocellular Carcinoma Tumor Burden Score is Associated with Grater Liver Transplant Survival Benefit

    H. Liu1, W. Zhang2, M. Di3, H. Lee4, R. Cruz1, X. Wang2, C. Kaltenmeier1, A. Thompson1, D. Reddy1, E. Ashwat1, M. D'Alesio1, S. Lebowitz1, S. Tohme1, D. Geller1, A. Tevar1, C. Hughes1, A. Humar1, J. Behari5, R. Bataller5, S. Hariharan5, M. Molinari1

    1Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 2Mathematics and Statistics, University of Arkansas at Little Rock, Little Rock, AR, 3Medicine, Medical Oncology, Yale University, New Haven, CT, 4Biostatistics, Massachusetts General Hospital, Boston, MA, 5Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: Liver transplantation(LT) is the best treatment option for early-stage hepatocellular carcinoma(HCC) and cirrhosis. However, patients with various tumor burdens receive identical listing priority, despite…
  • 2022 American Transplant Congress

    Does Machine Perfusion of Heart for Donation After Cardiac Death (DCD) Transplantation Affect Other Organ Outcomes?

    R. Misawa1, K. Okumura2, H. Sogawa1, G. Veillette1, A. Dhand3, R. Bodin4, D. C. Wolf4, B. Partiula4, D. John1, T. Diflo5, S. Nishida1

    1Department of Surgery, Transplant, Westchester Medical Center/New York Medical College, Valhalla, NY, 2Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY, 3Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY, 4Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY, 5Westchester Medical Center/New York Medical College, Valhalla, NY

    *Purpose: Machine perfusion of heart for donation after cardiac death (DCD) transplants is being increasingly utilized. Initial protocol of the heart machine perfusion for the…
  • 2022 American Transplant Congress

    Role for Club Cell Secretory Protein in Inducing Exosomes and Activation of Immune Responses in Lung Transplanted Recipients for Cystic Fibrosis

    R. Ravichandran1, V. Kaza2, R. Bremner1, M. Smith1, T. Mohanakumar1

    1St. Joseph’s Hospital and Medical Center, Phoenix, AZ, 2University of Texas Southwestern, Dallas, TX

    *Purpose: Our lab has demonstrated that lower club cell secretory protein leads to immune responses to donor HLA and lung self-antigens (Collagen V, Kα1 Tubulin),…
  • 2022 American Transplant Congress

    End-to-Side Splenic to Hepatic Artery Reconstruction in Liver Transplant: A Case Series

    N. Baker, L. Aviles-Ovalle, T. Baker, J. Campsen, R. Kim, G. Rofaiel

    Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT

    *Purpose: Optimal hepatic artery (HA) blood flow post-liver transplantation (LT) is necessary for long-term allograft success. HA thrombosis (HAT) contributes to significant morbidity and mortality…
  • 2022 American Transplant Congress

    Adoptive Transfer OfMesenchymal Stem Cells Activates Hedgehog/SMO/Gli1 Signaling And Inhibits STING-mediated Innate Immune Response In Liver Transplant Inflammatory Injury

    D. Xu1, X. Qu1, Y. Tian1, M. Sheng1, Y. Lin1, Y. Zhan1, F. M. Kaldas1, R. W. Busuttil1, D. G. Farmer1, J. W. Kupiec-Weglinski1, Q. Xia2, B. Ke1

    1Surgery, Dumont - UCLA Transplant Ctr, Los Angeles, CA, 2Liver Surgery, Shanghai Jiaotong University School of Medicine, Shanghai, China

    *Purpose: The stimulator of interferon genes (STING) pathway has been recognized as a crucial signaling cascade of the innate immune system. Activation of the Hedgehog…
  • 2022 American Transplant Congress

    Measurement of Physical Activity and Frailty in the Early Post-Operative Period After Liver Transplant Surgery: Single-Center Pilot Study Using Fitbit Watch

    T. Shamaa, L. Allenspach, O. Shamaa, S. Shimada, C. Crombez, O. Hage-Hassan, T. Kitajima, S. Yeddula, I. Bajjoka, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Robust physical activity after liver transplant (LT) is an important determinant of long-term health. Patient and providers assessments of perioperative physical activity do not…
  • 2022 American Transplant Congress

    Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells

    E. Landmann1, P. Ruiz1, A. Kurt1, E. Kodela1, M. Martinez-Llordella2, A. Sanchez-Fueyo1

    1King's College London, London, United Kingdom, 2Quell Therapeutics, London, United Kingdom

    *Purpose: Owing to their potent immune-modulatory properties, regulatory T cells (Tregs) have been explored as novel cell therapy to induce allograft tolerance, with first clinical…
  • 2022 American Transplant Congress

    Pure Laparoscopic Donor Right Hepatectomy (PLDRH) – Can It be a Standardized, Reproducible and Cost Effective Procedure?

    A. Kadimella, B. Palat, R. S

    HPB and Liver Transplantation, AIG Hospitals, Hyderabad, India

    *Purpose: Few centers in the world are doing PLDRH because of the long learning curve and donor safety concerns. Further longer operative time, difficulty in…
  • 2022 American Transplant Congress

    Resource Utilization in Liver Transplant Patients Based on Psychological Evaluation of High Risk vs. Non-High Risk

    K. Barber1, D. Chism2, R. Sauls3, R. Shargo3, M. Gosselin4, S. Mohammed3, K. Robichaux3, A. Kumar5, J. Buggs1

    1Transplant Surgery, Tampa General Hospital, Tampa, FL, 2Lake Erie College of Osteopathic Medicine, Bradenton, FL, 3University of South Florida, Tampa, FL, 4University of Tampa, Tampa, FL, 5Morsani College of Medicine, University of South Florida, Tampa, FL

    *Purpose: Psychological evaluation in liver transplant candidates helps to determine suitability. The psychological risk assessment results in the characterization of either low, medium, or high…
  • 2022 American Transplant Congress

    Are Autoimmune Conditions Disadvantaged Compared to Alcoholic Cirrhosis and Hepatocellular Carcinoma?

    S. S. Keeling

    Baylor College of Medicine, Houston, TX

    *Purpose: Orthotopic liver transplantation (OLT) is a lifesaving therapy for patients with irreversible liver damage caused by autoimmune liver diseases (ALD) including autoimmune hepatitis (AIH),…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences